Business Wire

NielsenIQ announces Tracey Massey as Chief Operating Officer

Share

Today, NielsenIQ, a global information services company, has named Tracey Massey as the company’s first Chief Operating Officer (COO). Reporting to the Chief Executive Officer and will oversee all commercial and product aspects, responsible for revenue, product development plans, business units’ strategies, and all market-facing aspects of NielsenIQ.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220609005234/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

“Tracey will play an integral role in the continued transformation of NielsenIQ, placing even more emphasis on sustainable growth through the execution of our strategic initiatives,” said Jim Peck, Executive Chairman and Chief Executive Officer of NielsenIQ. “She brings more than 30 years of industry experience and a successful track record in growing and expanding global business, but most importantly her passion for serving customers and nurturing highly engaged teams will be key in our evolution.”

Tracey most recently served as Global President and Chief Executive Officer of Mars Pet Nutrition, where she led the world’s largest pet food business, revamping its product portfolios for continuous growth under her leadership. Prior to that role, she was Regional President Mars Confectionary Americas, where she successfully led her team through the integration of Mars Chocolate Americas with the Wrigley Co. Americas.

“I am excited to join NielsenIQ and look forward to using my experience in the fast-moving consumer goods (FMCG) industry to help build a successful future for the company,” said Tracey Massey.

About NielsenIQ
NielsenIQ, a global information services company, delivers the gold standard in consumer and retail measurement, through the most connected, complete, and actionable understanding of the evolving global, omnichannel consumer. NielsenIQ is the source of confidence for the industries we serve and the pioneer defining the next century of consumer and retail measurement. Our data, connected insights, and predictive analytics optimize the performance of CPG and retail companies, bringing them closer to the communities they serve and helping to power their growth.

NielsenIQ, an Advent International portfolio company, has operations in 90+ markets, covering more than 90% of the world’s population. For more information, visit NielsenIQ.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media: Gillian Mosher, gillian.mosher@nielseniq.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Merck Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing16.4.2024 14:00:00 CEST | Press release

Merck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its kind. The Aptegra™ CHO genetic stability assay leverages whole genome sequencing and bioinformatics to significantly accelerate biosafety testing for clients and therefore, their move into commercial production. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416870388/en/ A scientist preparing samples in the next-generation sequencing laboratory at Merck’s Rockville, Maryland, USA site. (Photo: Business Wire) “Driving innovation in biosafety testing is essential to bringing new therapies to patients faster,” said Benjamin Hein, Head of Life Science Services, Life Science business of Merck. “CHO genetic stability testing has remained relatively unchanged for many years. The Aptegra™ platform transforms biosafety testing with a digital solution using next-generation sequencing.” Currently, FDA guidanc

XYZ Reality Welcomes Data Center Industry Leaders Christian Belady and Brian Mattson as Strategic Advisors16.4.2024 14:00:00 CEST | Press release

XYZ Reality, the leading engineering grade augmented reality (AR) platform for data center and mission critical construction, is proud to announce the appointment of data center industry veterans Christian Belady and Brian Mattson as Strategic Advisors. With their extensive experience and innovative vision, they will help guide XYZ Reality in enhancing its data center construction solution and product roadmap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416398782/en/ Christian Belady (Photo: Business Wire) Christian Belady, recognized as one of the "5 People who changed the data center" industry, brings a wealth of expertise in managing data center and infrastructure development at a global scale. Formerly Vice President and Distinguished Engineer at Microsoft, Belady developed one of the largest data center footprints in the world. Notably, during his tenure at Hewlett Packard, he was the innovator behind the Power Us

Q4 Inc. Charts Bold New Path for Investor Relations with AI-Driven IR Ops Platform16.4.2024 14:00:00 CEST | Press release

Q4 Inc. (“Q4” or “the Company”) is redefining investor relations with the IR Ops Platform, delivering a differentiated experience to their clients with seamless workflows and superior insights fueled by secure and private AI. Q4 is the only end-to-end IR Ops Platform designed to empower IR leaders to focus on strategy, building investor relationships, and driving premium valuations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416587263/en/ AI Earnings Co-Pilot (Photo: Business Wire) As the first IR Ops Platform, Q4 is eliminating piecemeal IR solutions by utilizing secure AI to create smart workflows that remove tedious administrative tasks that, if mishandled, could significantly impact Investor Relations Officers (“IROs”) and the organization. By leveraging AI, Q4 ensures accurate and efficient completion of these tasks, equipping IR teams with the capacity to focus on their strategic priorities. Gone are the days of

ExaGrid’s Tiered Backup Storage Named “Data Backup Solution of the Year” in 5 th Annual Data Breakthrough Awards Program16.4.2024 14:00:00 CEST | Press release

ExaGrid®, the industry’s only Tiered Backup Storage solution with Retention Time-Lock that includes a non-network-facing tier (creating a tiered air gap), delayed deletes and immutability for ransomware recovery, today announced that its Tiered Backup Storage has been selected as winner of the “Data Backup Solution of the Year” award in the 5th annual Data Breakthrough Awards program conducted by Data Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global data technology market today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416869303/en/ ExaGrid’s breakthrough Tiered Backup Storage provides comprehensive security, ransomware recovery, multiple disaster recovery options, and more. The solution writes backups directly to a disk-cache Landing Zone, avoiding inline processing and ensuring the highest level of backup performance, resulting

Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile16.4.2024 14:00:00 CEST | Press release

Masimo (NASDAQ: MASI) today announced that its Founder and CEO, Joe Kiani, will be a featured speaker tomorrow, April 17, at the 6th Global Ministerial Summit on Patient Safety. Kiani’s speech, “Empowering Patient Safety Through AI,” will discuss how artificial intelligence-based technologies, by analyzing both historical and immediate data, can help clinicians prevent errors of omission, improving patient safety, patient outcomes, and clinician efficiency. As Kiani will note, Masimo’s AI-powered medical technologies, including those used as part of the Masimo Hospital Automation™ family of solutions available today, can ease the burden of staffing shortages by improving clinician efficiency. Furthermore, by integrating and analyzing patient data from a variety of sources, in real time, such technology can provide greater situational awareness than alarms alone and help predict increases in patient risk, prompting clinicians to intervene sooner to catch physiological deterioration befo

HiddenA line styled icon from Orion Icon Library.Eye